Form 8-K - Current report:
SEC Accession No. 0001213900-25-038076
Filing Date
2025-05-01
Accepted
2025-05-01 09:07:42
Documents
18
Period of Report
2025-05-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0240182-8k_kronos.htm   iXBRL 8-K 59742
2 AGREEMENT AND PLAN OF MERGER, DATED MAY 1, 2025, BY AND AMONG CONCENTRA BIOSCIEN ea024018201ex2-1_kronos.htm EX-2.1 496079
3 FORM OF CONTINGENT VALUE RIGHTS AGREEMENT BY AND BETWEEN CONCENTRA BIOSCIENCES, ea024018201ex10-1_kronos.htm EX-10.1 146617
4 PRESS RELEASE OF KRONOS BIO, INC. DATED MAY 1, 2025 ea024018201ex99-1_kronos.htm EX-99.1 13700
5 GRAPHIC ex99-1_001.jpg GRAPHIC 3827
  Complete submission text file 0001213900-25-038076.txt   1097978

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE kron-20250501.xsd EX-101.SCH 3262
7 XBRL DEFINITION FILE kron-20250501_def.xml EX-101.DEF 26191
8 XBRL LABEL FILE kron-20250501_lab.xml EX-101.LAB 35951
9 XBRL PRESENTATION FILE kron-20250501_pre.xml EX-101.PRE 24849
20 EXTRACTED XBRL INSTANCE DOCUMENT ea0240182-8k_kronos_htm.xml XML 5060
Mailing Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402 (650) 781-5200
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39592 | Film No.: 25899818
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)